Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 63

Biotechnology

FDA approved first targeted therapy for subset of non-small cell lung cancer
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics

FDA approved first targeted therapy for subset of non-small cell lung cancer

On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…

Read More FDA approved first targeted therapy for subset of non-small cell lung cancerContinue

Japan’s Ministry of Health, Labour and Welfare approved Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Japan’s Ministry of Health, Labour and Welfare approved Moderna’s COVID-19 vaccine

On May 21, 2021, Moderna announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted…

Read More Japan’s Ministry of Health, Labour and Welfare approved Moderna’s COVID-19 vaccineContinue

Ministry of Food and Drug Safety of South Korea authorized Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine | WHO

Ministry of Food and Drug Safety of South Korea authorized Moderna’s COVID-19 vaccine

On May 21, 2021, Moderna announced that the Ministry of Food and Drug Safety of South Korea (MFDS)…

Read More Ministry of Food and Drug Safety of South Korea authorized Moderna’s COVID-19 vaccineContinue

Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxiv
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxiv

On May 21, 2021, Novavax announced that the full results from the Phase 3, randomized, observer-blinded, placebo-controlled trial…

Read More Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxivContinue

Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United Kingdom
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United Kingdom

On May 21, 2021, Novavax announced participation in a mix-and-match (vaccine interchangeability) COVID-19 vaccine booster trial that led…

Read More Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United KingdomContinue

EMA issued positive scientific opinion on GSK and Vir Biotechnologyメs sotrovimab for the early treatment of COVID-19
Biotechnology | Life Science History

EMA issued positive scientific opinion on GSK and Vir Biotechnologyメs sotrovimab for the early treatment of COVID-19

On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agencyメs (EMA) Committee for Human…

Read More EMA issued positive scientific opinion on GSK and Vir Biotechnologyメs sotrovimab for the early treatment of COVID-19Continue

Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY
Biotechnology | COVID-19 | Life Science History | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY

On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…

Read More Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATYContinue

Scientists discovered rare genetic condition that attacks kids’ immune systems
Biotechnology | Diagnostics | Therapeutics

Scientists discovered rare genetic condition that attacks kids’ immune systems

On May 19, 2021, Megan A. Cooper, MD, PhD, an associate professor of pediatrics at Washington University School…

Read More Scientists discovered rare genetic condition that attacks kids’ immune systemsContinue

Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical study
Biotechnology | COVID-19 | Therapeutics | Vaccine

Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical study

On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…

Read More Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical studyContinue

The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics

The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC

On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…

Read More The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBCContinue

Moderna announced new supply agreement with Australia for 25 million doses of its COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced new supply agreement with Australia for 25 million doses of its COVID-19 vaccine

On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…

Read More Moderna announced new supply agreement with Australia for 25 million doses of its COVID-19 vaccineContinue

INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies
Biotechnology | COVID-19 | Life Science History | Vaccine

INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies

On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…

Read More INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studiesContinue

InBios received FDA EUA for COVID-19 POC antigen detection test
Biotechnology | COVID-19 | Diagnostics | FDA

InBios received FDA EUA for COVID-19 POC antigen detection test

On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…

Read More InBios received FDA EUA for COVID-19 POC antigen detection testContinue

InBios received FDA EUA for COVID-19 POC antigen detection test
Biotechnology | COVID-19 | Diagnostics | FDA

InBios received FDA EUA for COVID-19 POC antigen detection test

On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…

Read More InBios received FDA EUA for COVID-19 POC antigen detection testContinue

AquaBounty sold out first commercial harvest of genetically engineered Atlantic Salmon from its Indiana farm
Biotechnology | FDA | Marine Science

AquaBounty sold out first commercial harvest of genetically engineered Atlantic Salmon from its Indiana farm

On May 10, 2021, AquaBounty Technologies announced that purchase orders had been received for the planned harvest of…

Read More AquaBounty sold out first commercial harvest of genetically engineered Atlantic Salmon from its Indiana farmContinue

Novavax announced positive preclinical data for combination influenza and COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Novavax announced positive preclinical data for combination influenza and COVID-19 vaccine candidate

On May 10, 2021, Novavax announced data from a preclinical study of the company’s combination quadrivalent seasonal flu…

Read More Novavax announced positive preclinical data for combination influenza and COVID-19 vaccine candidateContinue

INOVIO announced positive data from phase 2 clinical trial evaluating INO-4800 COVID-19 DNA vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO announced positive data from phase 2 clinical trial evaluating INO-4800 COVID-19 DNA vaccine

On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…

Read More INOVIO announced positive data from phase 2 clinical trial evaluating INO-4800 COVID-19 DNA vaccineContinue

GSK and Vir Biotechnology announced start  of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
Biotechnology | COVID-19 | Life Science History

GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19

On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…

Read More GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19Continue

Moderna announced agreement with Switzerland for 7 million booster vaccine doses in 2022 with options
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced agreement with Switzerland for 7 million booster vaccine doses in 2022 with options

On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…

Read More Moderna announced agreement with Switzerland for 7 million booster vaccine doses in 2022 with optionsContinue

Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facility
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facility

On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…

Read More Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facilityContinue

Tufts Silklab Created Leather-like Material from Silk Proteins
Biotechnology | Materials

Tufts Silklab Created Leather-like Material from Silk Proteins

On May 5, 2021, researchers at Tufts University School of Engineering announced they had developed an alternative to…

Read More Tufts Silklab Created Leather-like Material from Silk ProteinsContinue

Moderna announced positive initial booster data against SARS-CoV-2 variants
Biotechnology | Infectious Disease | Therapeutics

Moderna announced positive initial booster data against SARS-CoV-2 variants

On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…

Read More Moderna announced positive initial booster data against SARS-CoV-2 variantsContinue

NEJM published phase 2b clinical trial results demonstrating efficacy of  COVID-19 vaccine against B.1.351 variant
Biotechnology | COVID-19 | Infectious Disease | Vaccine

NEJM published phase 2b clinical trial results demonstrating efficacy of COVID-19 vaccine against B.1.351 variant

On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…

Read More NEJM published phase 2b clinical trial results demonstrating efficacy of COVID-19 vaccine against B.1.351 variantContinue

Pfizer and BioNTech received Health Canada authorization of COVID-19 vaccine in adolescents
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Pfizer and BioNTech received Health Canada authorization of COVID-19 vaccine in adolescents

On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…

Read More Pfizer and BioNTech received Health Canada authorization of COVID-19 vaccine in adolescentsContinue

CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials

On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…

Read More CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trialsContinue

Moderna announced expansion of its manufacturing technology center in Massachusetts
Biotechnology | Infectious Disease | Vaccine

Moderna announced expansion of its manufacturing technology center in Massachusetts

On May 4, 2021, Moderna announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including…

Read More Moderna announced expansion of its manufacturing technology center in MassachusettsContinue

Researchers wirelessly recorded human brain activity during normal life activities
Biotechnology | Life Science History

Researchers wirelessly recorded human brain activity during normal life activities

On May 3, 2021, the National Institutes of Health announced that researchers wre able to wirelessly record the…

Read More Researchers wirelessly recorded human brain activity during normal life activitiesContinue

University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation
Biotechnology | Diagnostics

University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation

On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…

Read More University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutationContinue

Precipio launched Rapid COVID-19 Antibody test on Amazon platform
Biotechnology | COVID-19 | Diagnostics | FDA

Precipio launched Rapid COVID-19 Antibody test on Amazon platform

On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute)…

Read More Precipio launched Rapid COVID-19 Antibody test on Amazon platformContinue

Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX

On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500…

Read More Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAXContinue

Page navigation

Previous PagePrevious 1 … 61 62 63 64 65 … 169 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search